跳转至内容
Merck
CN
  • Sensory lesioning induces microglial synapse elimination via ADAM10 and fractalkine signaling.

Sensory lesioning induces microglial synapse elimination via ADAM10 and fractalkine signaling.

Nature neuroscience (2019-06-19)
Georgia Gunner, Lucas Cheadle, Kasey M Johnson, Pinar Ayata, Ana Badimon, Erica Mondo, M Aurel Nagy, Liwang Liu, Shane M Bemiller, Ki-Wook Kim, Sergio A Lira, Bruce T Lamb, Andrew R Tapper, Richard M Ransohoff, Michael E Greenberg, Anne Schaefer, Dorothy P Schafer
摘要

Microglia rapidly respond to changes in neural activity and inflammation to regulate synaptic connectivity. The extracellular signals, particularly neuron-derived molecules, that drive these microglial functions at synapses remain a key open question. Here we show that whisker lesioning, known to dampen cortical activity, induces microglia-mediated synapse elimination. This synapse elimination is dependent on signaling by CX3CR1, the receptor for microglial fractalkine (also known as CXCL1), but not complement receptor 3. Furthermore, mice deficient in CX3CL1 have profound defects in synapse elimination. Single-cell RNA sequencing revealed that Cx3cl1 is derived from cortical neurons, and ADAM10, a metalloprotease that cleaves CX3CL1 into a secreted form, is upregulated specifically in layer IV neurons and in microglia following whisker lesioning. Finally, inhibition of ADAM10 phenocopies Cx3cr1-/- and Cx3cl1-/- synapse elimination defects. Together, these results identify neuron-to-microglia signaling necessary for cortical synaptic remodeling and reveal that context-dependent immune mechanisms are utilized to remodel synapses in the mammalian brain.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
抗NG2硫酸软骨素蛋白聚糖抗体, Chemicon®, from rabbit
Sigma-Aldrich
抗-NeuN抗体, from chicken, purified by affinity chromatography
Sigma-Aldrich
抗 ATF3 兔抗, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
抗-Aldh1L1抗体,克隆N103/39, clone N103/39, from mouse
Sigma-Aldrich
Protein delivery system, Human CXCL1, PODS®